Navigation Links
FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market
Date:2/22/2010

l enrolling patients, with preliminary results expected by 2014. Responding to the criticism, GlaxoSmithKline noted Saturday that, "TIDE has been approved by an independent review board and appropriate safety boards that are responsible for assessing the safety of conducting the trial."

The ongoing controversy has dampened patients' and physicians' enthusiasm for Avandia. According to the Times, while sales of the drug topped $3.2 billion in 2006, those numbers plummeted soon after the first studies suggesting risk emerged a year later.

Still, "hundreds of thousands" of people still take Avandia, the Times noted. GlaxoSmithKline's patent on the drug expires in 2012.

More information

Find out more about diabetes care at the American Diabetes Association.



SOURCES; Feb. 22, 2010, statement, U.S. Food and Drug Administration; Carl J. Lavie, M.D., medical director, cardiac rehabilitation, and prevention director, Stress Testing Laboratory, Ochsner Heart and Vascular Institute, New Orleans; Bruce M. Psaty, M.D. Ph.D., University of Washington, Seattle; Feb. 20, 2010, news release, GlaxoSmithKline; Feb 20, 2010, The New York Times


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Spectranetics to Appeal Decision in Patent Litigation
4. Canadas government funds $1.6M in modern geography to support public health decisions
5. Parents participation in medical decisions linked to self-efficacy
6. Decision-making by residents on-call has miniscule negative impact on patient care
7. Political decisions harming cancer treatment in Europe
8. UniCare Introduces Consumer-Driven Health Products to Give Consumers a Bigger Role in Health Care Decisions
9. Equipping your Sales Force to Influence Hospital Formulary Decision-Makers
10. Newton-Wellesley Hospital First in Massachusetts to Implement Isabel Diagnosis Decision Support System
11. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... Seattle, Wa (PRWEB) July 26, 2014 ... book review recently updated by Vkool.com, this ... natural and safe methods for treating all ... including:,     Tinnitus due ... subjective tinnitus ,     Nerve pathway tinnitus ...
(Date:7/26/2014)... July 26, 2014 The U.S. Food & ... that includes a new medication guide for AndroGel to include ... side-effect of taking the topical low testosterone medication, notes Wright ... Inc., the makers of the low testosterone theapy drug, has ... pain, swelling or redness as signs of a blood clot ...
(Date:7/26/2014)... Wa (PRWEB) July 26, 2014 According ... updated by Vkool.com, this is a comprehensive guide that ... unwanted tattoos . This book also teaches them ... imitate common medical procedures in their own home for ... that "Get Rid Tattoo Naturally" book includes step-by-step tutorials ...
(Date:7/25/2014)... 2014 2014 Deep Research ... Chromatography Industry” is a professional and in-depth ... Gel Permeation Chromatography market. The report provides ... Permeation Chromatography definition, classification, application, and industry ... This research covers the international market analysis, ...
(Date:7/25/2014)... York (PRWEB) July 25, 2014 A ... summary judgment in two DePuy Pinnacle hip lawsuits ( ... way for the claims to go before a jury ... an opinion rendered on July 18th, U.S. District Judge ... that the two Plaintiffs’ claims may proceed to trial ...
Breaking Medicine News(10 mins):Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 3Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 5Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4
... of researchers led by A. K. Rajasekaran, PhD, Director of ... a key protein involved in cell function and regulation is ... work is published online in the American Journal of ... Cigarette smoke is well recognized as a cause of lung ...
... SEATTLE March 21, 2012: Anxiety, depression, stress ... drug use in youth, according to a study from ... researchers from the University of Washington and Seattle University. ... eighth grade who felt more emotional support from teachers ...
... 2012) Ching-Hon Pui, M.D., a renowned leader in the ... the 2012 Pediatric Oncology Award from the American Society of ... better understanding the blood cancer,s biology and treatment as well ... will receive the award in June at the 2012 ASCO ...
... challenges reading in Arabic than native Hebrew or English speakers ... the brain divide the labor differently when the brain processes ... the result of a new study conducted by two University ... Safra Brain Research Center for the Study of Learning Disabilities ...
... Non-small cell lung cancer (NSCLC), the most common form ... chemotherapy. However, a small group of patients can also ... New research published in BioMed Central,s open access journal ... epidermal growth factor receptor (EGFR) using RNAi, alongside TKI ...
... , TUESDAY, March 20 (HealthDay News) ... from the left and right arms might help predict ... new study suggests. Researchers found that people with ... each arm are at higher risk of cardiovascular death ...
Cached Medicine News:Health News:Nemours researchers uncover new evidence of cancer-causing agent present in gaseous phase of cigarette smoke 2Health News:Middle school teacher support lowers risk for early alcohol use 2Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 2Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 3Health News:Brain's involvement in processing depends on language's graphic symbols 2Health News:Brain's involvement in processing depends on language's graphic symbols 3Health News:Double whammy: RNAi enhances lung cancer therapy 2Health News:Blood Pressure Variance Between Arms Points to Heart Risk 2
(Date:7/24/2014)... HILDEN , Deutschland, und ... , ... ermöglicht QIAGEN die Entwicklung von ... Genpanels, für Blutkrebs  Neuer Test ... Patienten mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen ...
(Date:7/24/2014)...  Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... the prior year. Reported sales increased 5% which included ... per diluted share as reported (EPS) were $2.49, compared ... EPS was $2.57, an increase of 9% over the ...
(Date:7/24/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... company, today announced it has accepted  Damian Finio,s ... has accepted a senior level finance position at a ... of his new position, Mr. Finio will be unable ... Laboratories, Inc.  The effective date of his resignation will ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... 2012   OncoSec Medical Incorporated (OTCBB:ONCS), which ... ElectroOncology therapies to treat solid tumor cancers, today ... biomarker strategy with the goal of identifying and ... the selection of patients potentially responsive to the ...
... 8, 2012  S1 Pharmaceuticals, Inc., a developer of therapeutics for ... addition and Scientific Advisory Board appointment to strengthen and expand ... Pyke, MD, PhD, a member of the S1 Advisory Board ... Chief Medical Officer. , Molly A. Katz, MD was ...
Cached Medicine Technology:OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy 2OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy 3S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments 2S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: